US Patent Issued to EpicentRx on Feb. 2 for "Immunomodulatory fusion proteins" (California Inventors)

  • Christopher Larson

Press/Media

Period3 Feb 2021

Media coverage

1

Media coverage

  • TitleUS Patent Issued to EpicentRx on Feb. 2 for "Immunomodulatory fusion proteins" (California Inventors)
    Media name/outletUS Fed News
    Country/TerritoryUnited States
    Date3/02/21
    PersonsChristopher Larson
View all 1
View less